# Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients

> **NCT03946514** · PHASE4 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 180 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** losartan/hydrochlorothiazide
- **DRUG:** amlodipine/hydrochlorothiazide

## Key facts

- **NCT ID:** NCT03946514
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03946514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03946514, "Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03946514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*